Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 22
  • Journal CiteScore: 7.55
  • Journal Impact Factor: 6.38
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
Share This Page


Antimicrobial Evaluation of Methicillin-Resistant Staphylococcus Aureus Nasal Carriage amongst Healthy Students in Agbor, Delta State, Nigeria

Ugwu MC, Anie CO, Ibezim EC and Esimone CO

The antibacterial susceptibility of Methicillin resistant Staphylococcus aureus isolated from the nostrils of students of College of Education Agbor, Nigeria was investigated. Three hundred (300) specimens was collected from 150 male and 150 female students and cultured on appropriate bacteriological media. The bacterial isolates (S. aureus) were identified by standard biochemical tests. The MRSA was determined using Oxacillin antibiotic disk. Antibiotic susceptibility of the isolates was performed according to Clinical Laboratory Standard testing Institute (CLSI) guidelines. Of the 300 nasal swab samples collected and screened, a total 218 (72.7%) of the isolates were found to be S. aureus based on morphology and biochemical tests. The incidence rate from female to male individuals were 103 (68.6%) and 115 (76.6%) respectively. The prevalence rate/ colonization of MRSA among healthy individuals in the community of the S. aureus isolated was 56 (18.7%). The antibiotic resistant pattern of the MRSA isolates was: Amoxicillin 30 (54%) > Streptomycin 25 (45%) >Amoxicillin-clavulanic acid 14 (25%), >Erythromycin 13 (23%) >Chloramphenicol 12 (21%),> Co-trimoxazole 10 (18%),>Ofloxacin 8 (13%),> Ciprofloxacin 9 (16%) > Gentamicin 5 (9%). The MRSA isolates showed multiple drug resistance to the beta-lactam and other commonly used antibiotics.